Further safety issues lead to clinical hold for DMD gene therapy
Solid Biosciences announces that its gene therapy for DMD has been placed under clinical hold again, after a patient experienced a serious adverse event.
Archives for November 13, 2019
Allogene allies with Notch to make CAR-T production more scalable
Allogene Therapeutics forms alliance with Notch Therapeutics to access technology for large-scale production of CAR-T therapies.